The metabolic and microcirculatory impact of orthotopic liver transplantation on the obese Zucker rat

Transplantation

Volumn 75, Issue 6, 2003, Pages 761-769

  Sun, Cheuk Kwan ^a   Zhang, Xing Yi ^a   Zimmermann, Arthur ^b   Wheatley, Antony M ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLYCOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; FLUORESCENCE MICROSCOPY; LASER DOPPLER FLOWMETRY; LIPID BLOOD LEVEL; LIVER BIOPSY; LIVER CELL; LIVER TRANSPLANTATION; LIVER WEIGHT; MALE; METABOLISM; MICROCIRCULATION; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT; RAT STRAIN;

ANIMALS; BIOPSY; BODY WEIGHT; CHOLESTEROL; CHOLESTEROL, HDL; FATTY LIVER; GLYCOGEN; GRAFT SURVIVAL; LIVER CIRCULATION; LIVER TRANSPLANTATION; MALE; MICROCIRCULATION; OBESITY; RATS; RATS, ZUCKER; TRIGLYCERIDES;

EID: 0037468712     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000054680.70476.70     Document Type: Article

References (55)

1. Kim WR, Poterucha JJ, Porayko MK, et al. Recurrence of nonalcoholic steatohepatitis following liver transplantation. Transplantation 1996; 62: 1802.
2. Silverman JF, O'Brien KF, Long S, et al. Liver pathology in morbidly obese patients with and without diabetes. Am J Gastroenterol 1990; 85: 1349.
3. McCullough A. Update on nonalcoholic fatty liver disease. J Clin Gastroenterol 2002; 34: 255.
4. Clain DJ, Lefkowitch JH. Fatty liver disease in morbid obesity. Gastroenterol Clin North Am 1987; 16: 239.
5. Ludwig J, McGill DB, Lindor KD. Review: Nonalcoholic steatohepatitis. J Gastroenterol Hepatol 1997; 12: 398.
6. Thaler H. Fatty liver. Tokai J Exp Clin Med 1980; 5: 233.
7. Fishbein TM, Fiel MI, Emre S, et al. Use of livers with microvesicular fat safely expands the donor pool. Transplantation 1997; 64: 248.
8. Carson K, Washington MK, Treem WR, et al. Recurrence of nonalcoholic steatohepatitis in a liver transplant recipient. Liver Transpl Surg 1997; 3: 174.
9. Czaja AJ. Recurrence of nonalcoholic steatohepatitis after liver transplantation. Liver Transpl Surg 1997; 3: 185.
10. Yang S, Lin HZ, Hwang J, et al. Hepatic hyperplasia in noncirrhotic fatty livers: Is obesity-related hepatic steatosis a premalignant condition? Cancer Res 2001; 61: 5016.
11. Chua SC Jr., Chung WK, Wu-Peng XS, et al. Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor. Science 1996; 271: 994.
12. Frederich RC, Lollmann B, Hamann A, et al. Expression of ob mRNA and its encoded protein in rodents: Impact of nutrition and obesity. J Clin Invest 1995; 96: 1658.
13. Triscari J, Bryce GF, Sullivan AC. Metabolic consequences of fasting in old lean and obese Zucker rats. Metabolism 1980; 29: 377.
14. Bach AC, Bois-Joyeux B, Chanez M, et al. Metabolic effects of medium- or long-chain triglycerides and high-protein, carbohydrate-free diets in Zucker rats. Metabolism 1984; 33: 951.
15. Liszka TG, Dellon AL, Im M, et al. Effect of lipectomy on growth and development of hyperinsulinemia and hyperlipidemia in the Zucker rat. Plast Reconstr Surg 1998; 102: 1122.
16. Bergeron R, Previs SF, Cline GW, et al. Effect of 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside infusion on in vivo glucose and lipid metabolism in lean and obese Zucker rats. Diabetes 2001; 50: 1076.
17. Sun CK, Zhang XY, Zimmermann A, et al. Effect of ischemia-reperfusion injury on the microcirculation of the steatotic liver of the Zucker rat. Transplantation 2001; 72: 1625.
18. Fukumori T, Ohkohchi N, Tsukamoto S, et al. The mechanism of injury in a steatotic liver graft during cold preservation. Transplantation 1999; 67: 195.
19. Wardlaw GM, Kaplan ML. Oxygen consumption and oxidative capacity of hepatocytes from young male obese and nonobese Zucker rats. Proc Soc Exp Biol Med 1986; 183: 199.
20. Sato N, Eguchi H, Inoue A, et al. Hepatic microcirculation in Zucker fatty rats. Adv Exp Med Biol 1986; 200: 477.
21. Zhang XY, Kuznetsova LV, Zimmermann A, et al. Successful hepatic grafting after partial portal vein ligation in the rat: Complete reversal of hemodynamic abnormalities. Transplantation 2000; 69: 3.
22. Zhao D, Zimmermann A, Wheatley AM. Morphometry of the liver after liver transplantation in the rat: Significance of an intact arterial supply. Hepatology 1993; 17: 310.
23. Zhang XY, Wheatley AM. Application of a new sleeve anastomosis technique to graft rearterialization in rat liver transplantation. Microsurgery 1996; 17: 472.
24. Vollmar B, Siegmund S, Menger MD. An intravital fluorescence microscopic study of hepatic microvascular and cellular derangements in developing cirrhosis in rats. Hepatology 1998; 27: 1544.
25. Zhang XY, Sun CK, Wheatley AM. A novel approach to the quantification of hepatic stellate cells in intravital fluorescence microscopy of the liver using a computerized image analysis system. Microvasc Res 2000; 60: 232.
26. Wheatley AM, Zhao D. Intraoperative assessment by laser Doppler flowmetry of hepatic perfusion during orthotopic liver transplantation in the rat. Transplantation 1993; 56: 1315.
27. Almond NE, Wheatley AM. Measurement of hepatic perfusion in rats by laser Doppler flowmetry. Am J Physiol 1992; 262: G203.
28. Abadie JM, Malcom GT, Porter JR, et al. Can associations between free fatty acid levels and metabolic parameters determine insulin resistance development in obese Zucker rats? Life Sci 2001; 69: 2675.
29. Schonfeld G, Pfleger B. Overproduction of very low-density lipoproteins by livers of genetically obese rats. Am J Physiol 1983; 244: R400.
30. Berke BM, Kaplan ML. Effects of high fat and high carbohydrate diets on development of hepatic and adipose lipogenesis in fa/fa and non-fa/fa rats. J Nutr 1983; 113: 820.
31. Wheatley AM, Stuart ET, Zhao D, et al. Effect of orthotopic transplantation and chemical denervation of the liver on hepatic hemodynamics in the rat. J Hepatol 1993; 19: 442.
32. Lautt WW. Effect of stimulation of hepatic nerves on hepatic O2 uptake and blood flow. Am J Physiol 1977; 232: H652.
33. Perseghin G, Regalia E, Battezzati A, et al. Regulation of glucose homeostasis in humans with denervated livers. J Clin Invest 1997; 100: 931.
34. Schneiter P, Gillet M, Chiolero R, et al. Postprandial hepatic glycogen synthesis in liver transplant recipients. Transplantation 2000; 69: 978.
35. Patsch JR, Patsch W. Exercise, high density lipoproteins, and fat tolerance. Compr Ther 1984; 10: 29.
36. Bach A, Bauer M, Schirardin H. Data on lipid metabolism in the genetically obese Zucker rat. Life Sci 1977; 20: 541.
37. Zucker LM. Hereditary obesity in the rat associated with hyperlipemia. Ann N Y Acad Sci 1965; 131: 447.
38. Alarrayed F, Hartman AD, Porter JR. Is there a role for the adrenals in the development of hypercholesterolemia in Zucker fatty rats? Am J Physiol 1992; 263: E287.
39. Fukuda N, Azain MJ, Ontko JA. Altered hepatic metabolism of free fatty acids underlying hypersecretion of very low density lipoproteins in the genetically obese Zucker rats. J Biol Chem 1982; 257: 14066.
40. Seifalian AM, Piasecki C, Agarwal A, et al. The effect of graded steatosis on flow in the hepatic parenchymal microcirculation. Transplantation 1999; 68: 780.
41. Tawadrous MN, Zhang XY, Wheatley AM. Microvascular origin of laser-Doppler flux signal from the surface of normal and injured liver of the rat. Microvasc Res 2001; 62: 355.
42. Yoong KF, Gunson BK, Neil DA, et al. Impact of donor liver microvesicular steatosis on the outcome of liver retransplantation. Transplant Proc 1999; 31: 550.
43. Wanless IR, Lentz JS. Fatty liver hepatitis (steatohepatitis) and obesity: An autopsy study with analysis of risk factors. Hepatology 1990; 12: 1106.
44. Marchesini G, Brizi M, Morselli-Labate AM, et al. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med 1999; 107: 450.
45. Triscari J, Stern JS, Johnson PR, et al. Carbohydrate metabolism in lean and obese Zucker rats. Metabolism 1979; 28: 183.
46. Aiston S, Agius L. Leptin enhances glycogen storage in hepatocytes by inhibition of phosphorylase and exerts an additive effect with insulin. Diabetes 1999; 48: 15.
47. Aiston S, Peak M, Agius L. Impaired glycogen synthesis in hepatocytes from Zucker fatty fa/fa rats: The role of increased phosphorylase activity. Arch Biochem Biophys 2000; 373: 249.
48. Muller C, Assimacopoulos-Jeannet F, Mosimann F, et al. Endogenous glucose production, gluconeogenesis and liver glycogen concentration in obese non-diabetic patients. Diabetologia 1997; 40: 463.
49. Kasiske BL, O'Donnell MP, Cleary MP, et al. Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats [erratum appears in Kidney Int 1988; 33(6): 1216]. Diabetes 1983; 32: 804.
50. Lee CS, Mauer SM, Brown DM, et al. Renal transplantation in diabetes mellitus in rats. J Exp Med 1974; 139: 793.
51. Parola M, Robino G. Oxidative stress-related molecules and liver fibrosis. J Hepatol 2001; 35: 297.
52. Matteoni C, Younossi Z, Gramlich T, et al. Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity. Gastroenterology 1999; 116: 1413.
53. Keeffe EB, Adesman PW, Stenzel P, et al. Steatosis and cirrhosis in an obese diabetic: Resolution of fatty liver by fasting. Dig Dis Sci 1987; 32: 441.
54. Terao T, Fujise T, Yamashita Y, et al. Dependence of lipid-lipoprotein metabolism on exercise intensity in experimental fatty liver rats. Tokai J Exp Clin Med 1988; 13: 99.
55. Laurin J, Lindor KD, Crippin JS, et al. Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: A pilot study. Hepatology 1996; 23: 1464.